{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:05:25Z","timestamp":1790240725359,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.blre.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T03:01:52Z","timestamp":1460257312000},"page":"333-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Extramedullary acute myelogenous leukemia"],"prefix":"10.1016","volume":"30","author":[{"given":"Melhem","family":"Solh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad","family":"Bashey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2016.04.001_bb0005","series-title":"Observations of Surgical Anatomy in Head and Neck","author":"Burns","year":"1811"},{"key":"10.1016\/j.blre.2016.04.001_bb0010","first-page":"97","article-title":"A case of chloroma","volume":"17","author":"King","year":"1853","journal-title":"Monthly J Med"},{"key":"10.1016\/j.blre.2016.04.001_bb0015","series-title":"Atlas of Tumor Pathology III","article-title":"Tumors of the Hematopoeitic System","author":"Rappaport","year":"1967"},{"issue":"5-6","key":"10.1016\/j.blre.2016.04.001_bb0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s002770050350","article-title":"Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation","volume":"75","author":"Szomor","year":"1997","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.blre.2016.04.001_bb0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1309\/AJCP1ZA7HYZKAZHS","article-title":"Myeloid sarcoma: extramedullary manifestation of myeloid disorders","volume":"132","author":"Campidelli","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.blre.2016.04.001_bb0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1503\/cmaj.080674","article-title":"Granulocytic sarcoma of the skin","volume":"179","author":"Pirisi","year":"2008","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.blre.2016.04.001_bb0035","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G","article-title":"Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases","volume":"48","author":"Neiman","year":"1981","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.blre.2016.04.001_bb0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbmt.2011.05.023","article-title":"Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse","volume":"18","author":"Solh","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.blre.2016.04.001_bb0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2009.12.034","article-title":"MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele","volume":"17","author":"Thiel","year":"2010","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.blre.2016.04.001_bb0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/13776","article-title":"The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia","volume":"23","author":"Castilla","year":"1999","journal-title":"Nat Genet"},{"issue":"4 Suppl. 3","key":"10.1016\/j.blre.2016.04.001_bb0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1053\/shem.2002.36921","article-title":"Molecular genetics of human leukemias: new insights into therapy","volume":"39","author":"Gilliland","year":"2002","journal-title":"Semin Hematol"},{"issue":"16","key":"10.1016\/j.blre.2016.04.001_bb0060","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1073\/pnas.1531730100","article-title":"An activated receptor tyrosine kinase, TEL\/PDGFbetaR, cooperates with AML1\/ETO to induce acute myeloid leukemia in mice","volume":"100","author":"Grisolano","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.blre.2016.04.001_bb0065","first-page":"823","article-title":"Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56)","volume":"8","author":"Seymour","year":"1994","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.blre.2016.04.001_bb0070","first-page":"275","article-title":"Immunohistochemical analysis of neural cell adhesion molecules. Differential expression in small round cell tumors of childhood and adolescence","volume":"139","author":"Garin-Chesa","year":"1991","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.blre.2016.04.001_bb0075","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0145-2126(89)90042-8","article-title":"Phenotyping of acute myelomonocytic (AMMOL) and monocytic leukemia (AMOL): association of T-cell-related antigens and skin-infiltration in AMOL","volume":"13","author":"Schwonzen","year":"1989","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.blre.2016.04.001_bb0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1182\/blood.V35.3.361.361","article-title":"Granulocytic sarcoma (chloroma)","volume":"35","author":"Wiernik","year":"1970","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2016.04.001_bb0085","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/1097-0142(197304)31:4<948::AID-CNCR2820310428>3.0.CO;2-N","article-title":"Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, Hiroshima-Nagasaki 1949\u20131969","volume":"31","author":"Liu","year":"1973","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.blre.2016.04.001_bb0090","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/1097-0142(19861215)58:12<2697::AID-CNCR2820581225>3.0.CO;2-R","article-title":"Granulocytic sarcoma in nonleukemic patients","volume":"58","author":"Meis","year":"1986","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.blre.2016.04.001_bb0095","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biopha.2012.10.014","article-title":"Is there a \u201cgold\u201d standard treatment for patients with isolated myeloid sarcoma?","volume":"67","author":"Antic","year":"2013","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.blre.2016.04.001_bb0100","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/cncr.10399","article-title":"Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature","volume":"94","author":"Yamauchi","year":"2002","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.blre.2016.04.001_bb0105","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1182\/blood.V124.21.2270.2270","article-title":"The prevalence of extramedullary AML detected by 18-FDG\/PET-CT: results from the prospective PET-AML trial","volume":"124","author":"Stolzel","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2016.04.001_bb0110","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.bbmt.2012.05.010","article-title":"Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: an easily overlooked but significant pattern of relapse","volume":"18","author":"Yoshihara","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.blre.2016.04.001_bb0115","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.leukres.2013.08.017","article-title":"Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia","volume":"37","author":"Shimizu","year":"2013","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.blre.2016.04.001_bb0120","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.1993.11.4.690","article-title":"Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia","volume":"11","author":"Tallman","year":"1993","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.blre.2016.04.001_bb0125","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2016.04.001_bb0130","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.leukres.2010.01.009","article-title":"Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature","volume":"34","author":"Zhang","year":"2010","journal-title":"Leuk Res"},{"issue":"12","key":"10.1016\/j.blre.2016.04.001_bb0135","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1080\/10428190600967196","article-title":"Granulocytic sarcoma: 32 cases and review of the literature","volume":"47","author":"Paydas","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.blre.2016.04.001_bb0140","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijscr.2014.02.003","article-title":"Relapse of acute myeloid leukemia manifested by cholecystitis: a case report and review of the literature","volume":"5","author":"Azin","year":"2014","journal-title":"Int J Surg Case Rep"},{"issue":"6","key":"10.1016\/j.blre.2016.04.001_bb0145","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3109\/10428194.2014.963080","article-title":"Presentation and outcomes among patients with isolated myeloid sarcoma: a surveillance, epidemiology, and end results database analysis","volume":"56","author":"Movassaghian","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.blre.2016.04.001_bb0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00277-001-0412-9","article-title":"A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis","volume":"81","author":"Agis","year":"2002","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.blre.2016.04.001_bb0155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1346-8138.2010.00823.x","article-title":"Leukemia cutis limited to the needle puncture sites","volume":"37","author":"Kim","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.blre.2016.04.001_bb0160","series-title":"Annals of 53 American Society of Hematology Annual Meeting and Exposition","article-title":"Extramedullary leukemia and myeloid sarcoma in AML: new clues to an old issue. Results of a retrospective population-based registry-study of 2261 patients","volume":"118 (21)","author":"Ostgaard","year":"2011"},{"issue":"5","key":"10.1016\/j.blre.2016.04.001_bb0165","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/jcm4051102","article-title":"Intracranial CNS manifestations of myeloid sarcoma in patients with acute myeloid leukemia: review of the literature and three case reports from the author's institution","volume":"4","author":"Cervantes","year":"2015","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.blre.2016.04.001_bb0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/pbc.22511","article-title":"The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study","volume":"55","author":"Johnston","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.blre.2016.04.001_bb0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.26253","article-title":"Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease","volume":"118","author":"Shihadeh","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2016.04.001_bb0180","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12885-015-1376-9","article-title":"Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults","volume":"15","author":"Cheng","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.blre.2016.04.001_bb0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1097-0339(200101)24:1<53::AID-DC1009>3.0.CO;2-D","article-title":"Unusual presentation of granulocytic sarcoma in the breast: a case report and review of the literature","volume":"24","author":"Ngu","year":"2001","journal-title":"Diagn Cytopathol"},{"issue":"2","key":"10.1016\/j.blre.2016.04.001_bb0190","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.blre.2016.04.001_bb0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5858\/2003-127-42-FCAOA","article-title":"Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data","volume":"127","author":"Kaleem","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.blre.2016.04.001_bb0200","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3324\/haematol.2011.045047","article-title":"(1)(8)F-FDG-PET\/CT for detection of extramedullary acute myeloid leukemia","volume":"96","author":"Stolzel","year":"2011","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.blre.2016.04.001_bb0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ejh.12085","article-title":"Extramedullary disease in patients with acute myeloid leukemia assessed by 18F-FDG PET","volume":"90","author":"Cribe","year":"2013","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.blre.2016.04.001_bb0210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000253592","article-title":"Prognostic factors of treatment outcomes in patients with granulocytic sarcoma","volume":"122","author":"Lan","year":"2009","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1016\/j.blre.2016.04.001_bb0215","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.1997.15.2.466","article-title":"Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461","volume":"15","author":"Byrd","year":"1997","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.blre.2016.04.001_bb0220","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cncr.23691","article-title":"Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.blre.2016.04.001_bb0225","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/ajh.23821","article-title":"Core-binding factor acute myeloid leukemia: heterogeneity, monitoring, and therapy","volume":"89","author":"Solh","year":"2014","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.blre.2016.04.001_bb0230","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.leu.2404699","article-title":"Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas","volume":"21","author":"Falini","year":"2007","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.blre.2016.04.001_bb0235","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2141.2004.05124.x","article-title":"FLT3 mutations in myeloid sarcoma","volume":"126","author":"Ansari-Lari","year":"2004","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.blre.2016.04.001_bb0240","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/sj.leu.2402958","article-title":"Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy","volume":"17","author":"Tsimberidou","year":"2003","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.blre.2016.04.001_bb0245","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"Dohner","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.blre.2016.04.001_bb0250","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/sj.leu.2401118","article-title":"Early detection of AML1\/MTG8 fusion mRNA by RT-PCR in the bone marrow cells from a patient with isolated granulocytic sarcoma","volume":"12","author":"Hayashi","year":"1998","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.blre.2016.04.001_bb0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0971-5851.116195","article-title":"Management of isolated recurrence of extramedullary myeloid tumor at a single site","volume":"34","author":"Krishna","year":"2013","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"5","key":"10.1016\/j.blre.2016.04.001_bb0260","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7326\/0003-4819-123-5-199509010-00005","article-title":"Isolated chloroma: the effect of early antileukemic therapy","volume":"123","author":"Imrie","year":"1995","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1016\/j.blre.2016.04.001_bb0265","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1182\/blood.V124.21.960.960","article-title":"The addition of radiation therapy to initial treatment for extramedullary acute leukemia does not offer a survival benefit when added to chemotherapy","volume":"124","author":"Feller","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2016.04.001_bb0270","first-page":"265","article-title":"Granulocytic sarcoma: a systematic review","volume":"3","author":"Yilmaz","year":"2013","journal-title":"Am J Blood Res"},{"issue":"27","key":"10.1016\/j.blre.2016.04.001_bb0275","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2012.47.4874","article-title":"Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial","volume":"31","author":"Burnett","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2016.04.001_bb0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.V124.21.3728.3728","article-title":"FLAG-idarubicin is superior to cytarabine plus idarubicin (7+3) for initial treatment of acute myeloid leukemia (AML): a multivariable analysis of patients treated at a single center","volume":"124","author":"Mihelic","year":"2014","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.blre.2016.04.001_bb0285","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa0901409","article-title":"High-dose daunorubicin in older patients with acute myeloid leukemia","volume":"361","author":"Lowenberg","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.blre.2016.04.001_bb0290","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.2009.23.2652","article-title":"Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study","volume":"28","author":"Pautas","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.blre.2016.04.001_bb0295","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1200\/JCO.1993.11.1.116","article-title":"Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy","volume":"11","author":"Gandhi","year":"1993","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.blre.2016.04.001_bb0300","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3324\/haematol.2014.114611","article-title":"Post-remission therapy for acute myeloid leukemia","volume":"99","author":"Schlenk","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.blre.2016.04.001_bb0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2012-07-444851","article-title":"Sense and nonsense of high-dose cytarabine for acute myeloid leukemia","volume":"121","author":"Lowenberg","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2016.04.001_bb0310","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2015-08-604520","article-title":"An update of current treatments for adult acute myeloid leukemia","volume":"127","author":"Dombret","year":"2016","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.blre.2016.04.001_bb0315","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1200\/JCO.2011.38.9429","article-title":"Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia","volume":"30","author":"Kantarjian","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.blre.2016.04.001_bb0320","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood-2015-01-621664","article-title":"International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts","volume":"126","author":"Dombret","year":"2015","journal-title":"Blood"},{"issue":"30","key":"10.1016\/j.blre.2016.04.001_bb0325","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1200\/JCO.2007.15.6315","article-title":"Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC","volume":"26","author":"Chevallier","year":"2008","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.blre.2016.04.001_bb0330","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/bmt.2015.82","article-title":"Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome","volume":"50","author":"Goyal","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.blre.2016.04.001_bb0335","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/leu.2012.156","article-title":"Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma","volume":"26","author":"Shimizu","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.blre.2016.04.001_bb0340","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbmt.2014.11.683","article-title":"Central nervous system involvement in acute myeloid leukemia patients undergoing hematopoietic cell transplantation","volume":"21","author":"Bar","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.blre.2016.04.001_bb0345","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1200\/JCO.1995.13.7.1800","article-title":"Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review","volume":"13","author":"Byrd","year":"1995","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.blre.2016.04.001_bb0350","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/ajco.12058","article-title":"Is extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation associated with improved survival?","volume":"9","author":"Curley","year":"2013","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.blre.2016.04.001_bb0355","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood.V126.23.1960.1960","article-title":"T cell replete HLA-haploidentical donor transplantation (HIDT) with post-transplant cyclophosphamide (pTcy) is an effective salvage for patients relapsing after a matched sibling or a matched unrelated donor transplantation","volume":"126","author":"Solh","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2016.04.001_bb0360","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/bmt.2012.256","article-title":"Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation","volume":"48","author":"Antar","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"23","key":"10.1016\/j.blre.2016.04.001_bb0365","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1002\/cncr.25500","article-title":"Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study","volume":"116","author":"de Lima","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2016.04.001_bb0370","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1182\/blood.V124.21.3964.3964","article-title":"A multicenter Phase I study of CTLA-4 blockade with ipilimumab for relapsed hematologic malignancies after allogeneic hematopoeitic cell transplantation","volume":"124","author":"Davids","year":"2014","journal-title":"Blood"},{"issue":"29","key":"10.1016\/j.blre.2016.04.001_bb0375","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1200\/JCO.2013.48.8783","article-title":"Phase I study of quizartinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication status","volume":"31","author":"Cortes","year":"2013","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.blre.2016.04.001_bb0380","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/cncr.28705","article-title":"Treatment with FLT3 inhibitor in patients with FLT3-mutated acute myeloid leukemia is associated with development of secondary FLT3-tyrosine kinase domain mutations","volume":"120","author":"Alvarado","year":"2014","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.blre.2016.04.001_bb0385","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1038\/leu.2012.115","article-title":"Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia","volume":"26","author":"Stone","year":"2012","journal-title":"Leukemia"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16300091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16300091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T13:49:18Z","timestamp":1655473758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X16300091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0268960X16300091"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2016.04.001","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extramedullary acute myelogenous leukemia","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}